Drugdesigntech SA develops and commercializes innovative bioinformatics software solutions & services to support clients active in the biotherapeutics and small molecule drug discovery field. Drugdesigntech SA was founded in 2007 and is based in Geneva, Switzerland. As trusted software development team and advisor to senior researchers of leading innovative companies, CROs, start-ups and academic institutions, Drugdesigntech SA follows a pragmatic approach that leverages IT in ways that are effective in a scientific research environment. Drugdesigntech SA markets the products Scaligner (https://www.scaligner.com), an antibody and next-generation sequence analysis platform with integrated data management system, and Biocorpora (https://www.biocorpora.com), a secure web-based data repository system to simplify scientific knowledge management and data sharing.
Looking for a particular Drugdesigntech SA employee's phone or email?
Drugdesigntech SA Questions
The Drugdesigntech SA annual revenue was $192000 in 2026.
Cédric Merlot is the CEO of Drugdesigntech SA.
2 people are employed at Drugdesigntech SA.
Drugdesigntech SA is based in Plan-les-Ouates, Geneva.
The NAICS codes for Drugdesigntech SA are [541, 5417, 54, 54171, 541713].
The SIC codes for Drugdesigntech SA are [87, 873].
Top Drugdesigntech SA Employees
-
Cédric Merlot
CEO at Drugdesigntech SA
Plan-les-Ouates, GE, CH2 -
Tina Riedel
Director Of Business Development at Drugdesigntech SA
Lausanne, VD, CH
Related Companies
